NCT00303433View on ClinicalTrials.gov

Namenda to Prevent Post-Operative Delirium

PHASE4TerminatedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

September 30, 2006

Conditions

DeliriumPost-Operative States

Interventions

DRUG

Namenda

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

University of Rochester

OTHER

NCT00303433 - Namenda to Prevent Post-Operative Delirium | Biotech Hunter | Biotech Hunter